Stemline Therapeutics reported U$1151 in Stock for its first quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Abbvie U$ 4059M 2215M
Amgen U$ 3840M 158M
Bristol Myers Squibb U$ 2384M 452M
Daiichi Sankyo Y 183663M 10301M
Eisai Y 70921M 5186M
GlaxoSmithKline 6396M 444M
Halozyme Therapeutics U$ 48.271M 6.819M
JAZZ PHA U$ 91.404M 1.13M
Johnson & Johnson 9599M 175M
Merk U$ 6056M 210M
Pfizer U$ 8564M 141M
Seattle Genetics U$ 90.002M 5.262M
Stemline Therapeutics U$ 1M 1M
Sumitomo Dainippon Y 78978M 390M
United Therapeutics U$ 89.7M 2.3M
Verastem U$ 6M 2M